EA Pharma Co., Ltd. is a gastrointestinal specialty pharma, established in April 2016 through the integration of the respective gastrointestinal business units of the Eisai Group and the Ajinomoto Group.

EA Pharma Co., Ltd. is an innovation-driven company, combining the accumulated experience and data (‘knowledge’) of the two Groups in drug discovery, clinical development, pharmacovigilance, manufacturing and marketing in the disease areas of the upper/lower gastrointestinal tract, the liver and the pancreas.